Basis of Presentation, Organization and Business and Summary of Significant Accounting Policies (Tables)

12 Months Ended

Jun. 30, 2017

Accounting Policies [Abstract]

Schedule of estimated future patent amortization expense

The following is a schedule of estimated future patent amortization expense as of June 30, 2017 during the following fiscal years: 

2018	$	116,375
2019		105,211
2020		81,782
2021		75,611
2022		49,642
Thereafter		290,515
	$	719,136

Schedule of number of weighted average common shares used in the calculation of Basic EPS and Diluted EPS

The number of weighted average common shares used in the calculation of Basic EPS and Diluted EPS were as follows:

	For the years ended June 30,
	2017		2016		2015
Basic shares		8,398,778		7,776,949		7,580,450
Dilutive effect of stock options		—		—		513,669
Diluted shares		8,398,778		7,776,949		8,094,119